arginine has been researched along with Addiction, Opioid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A; Başak Türkmen, N; Burr, K; Cao, HW; Cao, JR; Chan, JCY; Chen, J; Chen, Y; Christensen, BB; Çiftçi, O; Connelly, CD; de Mol, BA; Doğan, MF; Donahoe, LL; Dungchai, W; Fan, FF; Foldager, CB; Garvin, JL; Gonzalez-Vicente, A; Guan, J; He, P; Hede, KTC; Henry, CS; Hesek, A; Hong, NJ; Hossain, MJ; Huang, J; Huang, K; Hussain, S; Ishii, Y; Jeelani, SUY; Jiang, W; Keith, JP; Kelder, JC; Keshavjee, S; Khachornsakkul, K; Khadim, A; Kobayashi, N; Levenbrown, Y; Li, Y; Lim, SK; Lind, MC; Liu, H; Liu, X; Liu, Y; Lu, L; Luo, L; Lyu, CJ; Ma, Y; Mei, LH; Meredith, SC; Musharraf, SG; Nitin, N; Olesen, ML; Phoonsawat, K; Qian, G; Ratnarathorn, N; Ren, M; Saez, F; Şahin, Y; Scherpelz, KP; Shaffer, TH; Sun, G; Swinkels, BM; Taşlıdere, A; Ten Berg, JM; Thomsen, JS; Toh, WS; van Boven, WJ; Vermeulen, FE; Waddell, TK; Wang, HP; Wang, S; Wang, Z; Wei, B; Wickramasinghe, A; Woods, LM; Xiao, Y; Xu, C; Yamazaki, T; Yang, M; Yang, X; Yao, LL; Yasufuku, K; Yin, S; Yu, T; Zareena, B; Zhang, R; Zhuo, X | 1 |
| Amini-Khoei, H; Dehpour, A; Hassanipour, M; Imran-Khan, M; Rahimi, N; Rezayat, SM; Shafaroodi, H; Shirzadian, A | 1 |
| Gunduz, O; Karadag, CH; Ulugol, A | 1 |
| Galloway, GP; Kielstein, A; Mendelson, JE; Tsikas, D | 1 |
| Babey, AM; Kolesnikov, YA; Pasternak, GW | 1 |
| Kimes, AS; London, ED; Vaupel, DB | 1 |
3 review(s) available for arginine and Addiction, Opioid
| Article | Year |
|---|---|
Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?
Topics: Analgesics, Opioid; Arginine; Drug Tolerance; Humans; Nitric Oxide Synthase Type I; Opioid-Related Disorders; Pain | 2007 |
Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.
Topics: Animals; Arginine; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Morphine; Narcotics; Nitric Oxide Synthase; Nitroarginine; Opioid-Related Disorders; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, delta; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1995 |
Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Blood Pressure; Clonidine; Depression, Chemical; Enzyme Inhibitors; Heart Rate; Indazoles; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Opioid-Related Disorders; Ornithine; Substance Withdrawal Syndrome | 1995 |
3 other study(ies) available for arginine and Addiction, Opioid
| Article | Year |
|---|---|
Topics: Acetic Acid; Albumins; Alkaline Phosphatase; Alkaloids; Amyloid beta-Peptides; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Antioxidants; Aortic Valve; Aortic Valve Stenosis; Apoptosis; Arginine; Autophagy; Bacterial Proteins; Blood Vessel Prosthesis Implantation; Bone Marrow; Brain; Capsaicin; Cartilage, Articular; Cell Differentiation; Cell Wall; Cells, Cultured; Chlorine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Corn Oil; Dioxins; Disinfectants; Enzyme Stability; Enzymes, Immobilized; Escherichia coli O157; Extracellular Vesicles; Female; Food Contamination; gamma-Aminobutyric Acid; Gelatin; Glutamate Decarboxylase; Glutathione; Health Surveys; Heart Valve Prosthesis; Hemodynamics; Humans; Hypertension; Hypoxia; Infant, Newborn; Lactobacillus plantarum; Listeria; Loop of Henle; Lung Neoplasms; Male; Membranes, Artificial; Mesenchymal Stem Cells; Metabolome; Nitric Oxide; Nuclear Magnetic Resonance, Biomolecular; Opioid-Related Disorders; Oryza; Osteoblasts; Osteogenesis; Oxidants; Oxidative Stress; Plant Extracts; Polychlorinated Dibenzodioxins; Polylysine; Polysaccharides, Bacterial; Polyvinyls; Postoperative Complications; Pregnancy; Prescription Drug Misuse; Prosthesis Design; Protein Conformation; Proteins; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Rats, Wistar; Retrospective Studies; Risk Assessment; Risk Factors; Saccharomyces cerevisiae; Silver; Skull; Sodium Chloride; Sodium Chloride, Dietary; Sodium Glutamate; Spectrometry, Mass, Electrospray Ionization; Spinacia oleracea; Superoxide Dismutase; Superoxides; Swine; Swine, Miniature; Tandem Mass Spectrometry; Thiobarbituric Acid Reactive Substances; Time Factors; Tissue Engineering; Tissue Scaffolds; Transfection; Transforming Growth Factor beta1; Treatment Outcome; Wettability; X-Ray Microtomography | 2021 |
Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice.
Topics: Animals; Arginine; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Signal Transduction | 2016 |
Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice.
Topics: Animals; Arginine; Chromatography, High Pressure Liquid; Drug Tolerance; Homoarginine; Male; Mice; Mice, Inbred BALB C; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pain Measurement | 2010 |